Press release
Renal Cell Carcinoma FDA Approvals, Clinical Trials Assessment, Emerging Drugs and Companies | DelveInsight
Explore the comprehensive insights by DelveInsight and stay ahead in understanding the Renal Cell Carcinoma Treatment Landscape. Click here to read more @ Renal Cell Carcinoma Pipeline Outlook [https://www.delveinsight.com/sample-request/renal-cell-carcinoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Renal Cell Carcinoma Pipeline Report
* In January 2025:- Merck Sharp & Dohme LLC:- The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to placebo plus pembrolizumab, in the adjuvant treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy.
* In January 2025:- Hoffmann-La Roche:- A Phase III, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination With Cabozantinib Versus Cabozantinib Alone in Patients With Inoperable, Locally Advanced, or Metastatic Renal Cell Carcinoma Who Experienced Radiographic Tumor Progression During or After Immune Checkpoint Inhibitor Treatment.
* In January 2025:- Exelixis:- This is a multicenter, randomized, double-blinded, controlled Phase 3 trial of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in combination with matched placebo. Approximately 840 eligible subjects with intermediate- or poor-risk advanced or metastatic RCC by IMDC criteria will be randomized in a 1:1 ratio at approximately 180 sites.
* DelveInsight's Renal Cell Carcinoma Pipeline report depicts a robust space with 30+ active players working to develop 30+ pipeline therapies for Renal Cell Carcinoma treatment.
* The leading Renal Cell Carcinoma Companies such as AstraZeneca, Infinity Pharmaceuticals, Ipsen, Novartis, Aveao pharmaceuticals, Merck Sharp & Dohme Corp., Pfizer, Bayer Healthcare, Incyte Corporation, GlaxoSmithKline, Bristol-Myers Squibb, Hoffman La Roche, Amgen, ColImmune, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Betta Pharmaceuticals, Regeneron Pharmaceuticals, Cemiplimab, Aravivie Inc, X4 pharmaceuticals , and others.
* Promising Renal Cell Carcinoma Therapies such as PRO1160, Cabozantinib, CTX131, Ipilimumab, Nivolumab, Zanzalintinib, AB521, and others.
Discover groundbreaking developments in Renal Cell Carcinoma therapies! Gain in-depth knowledge of key Renal Cell Carcinoma clinical trials, emerging drugs, and market opportunities @ Renal Cell Carcinoma Clinical Trials Assessment [https://www.delveinsight.com/sample-request/renal-cell-carcinoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Renal Cell Carcinoma Emerging Drugs Profile
* CM082: Betta Pharmaceuticals
CM082 series have the similar skeletal structures to Icotinib Hydrochloride, as the multi-target RTK (receptor tyrosine kinase) inhibitor, mainly targeting at VEGFR and PDGFR. The drug is being evaluated in phase III stage of development for the treatment of Renal Cell Carcinoma.
* TQB 2450: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
TQB 2450 (formerly APL 502 and CBT 502) is a humanised immunoglobulin G1 (IgG1) monoclonal antibody targeting the programmed cell death-1 ligand-1. Phase III clinical trials are being evaluated by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. for TQB 2450 for the treatment of renal cell carcinoma.
* IPI-549: Infinity Pharmaceuticals
IPI-549 is an oral immuno-oncology candidate which has been designed to preferentially inhibit PI3K-gamma. The drug is being studied in phase II stage of development for the treatment of renal cell carcinoma.
* CMN-001: ColImmune
Dendritic cells have been used by colimmune for the treatment of renal failure. CMN001 is a dendritic cell vaccine for renal cell carcinoma. The drug is being evaluated in phase II stage of development for the treatment of renal cell carcinoma.
Stay informed about the Renal Cell Carcinoma pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Renal Cell Carcinoma Unmet Needs [https://www.delveinsight.com/sample-request/renal-cell-carcinoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Renal Cell Carcinoma Companies
AstraZeneca, Infinity Pharmaceuticals, Ipsen, Novartis, Aveao pharmaceuticals, Merck Sharp & Dohme Corp., Pfizer, Bayer Healthcare, Incyte Corporation, GlaxoSmithKline, Bristol-Myers Squibb, Hoffman La Roche, Amgen, ColImmune, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Betta Pharmaceuticals, Regeneron Pharmaceuticals, Cemiplimab, Aravivie Inc, X4 pharmaceuticals, and others.
Renal Cell Carcinoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
* Oral
* Subcutaneous
* Intravenous
* Intramuscular
* Molecule Type
Renal Cell Carcinoma Products have been categorized under various Molecule types such as
* Bispecific Antibody
* Peptides
* Small molecule
* Gene therapy
* Product Type
Transform your understanding of the Renal Cell Carcinoma Pipeline! See the latest progress in drug development and clinical research @ Renal Cell Carcinoma Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/renal-cell-carcinoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Renal Cell Carcinoma Pipeline Report
* Coverage- Global
* Renal Cell Carcinoma Companies- AstraZeneca, Infinity Pharmaceuticals, Ipsen, Novartis, Aveao pharmaceuticals, Merck Sharp & Dohme Corp., Pfizer, Bayer Healthcare, Incyte Corporation, GlaxoSmithKline, Bristol-Myers Squibb, Hoffman La Roche, Amgen, ColImmune, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Betta Pharmaceuticals, Regeneron Pharmaceuticals, Cemiplimab, Aravivie Inc, X4 pharmaceuticals, and others.
* Renal Cell Carcinoma Therapies- PRO1160, Cabozantinib, CTX131, Ipilimumab, Nivolumab, Zanzalintinib, AB521, and others.
* Renal Cell Carcinoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Renal Cell Carcinoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Stay Ahead in Oncology Research-Access the Full Renal Cell Carcinoma Pipeline Analysis Today! @ Renal Cell Carcinoma Drugs and Companies [https://www.delveinsight.com/sample-request/renal-cell-carcinoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Renal Cell Carcinoma Executive Summary
* Renal Cell Carcinoma: Overview
* Renal Cell Carcinoma Pipeline Therapeutics
* Renal Cell Carcinoma Therapeutic Assessment
* Renal Cell Carcinoma - DelveInsight's Analytical Perspective
* In-depth Commercial Assessment
* Renal Cell Carcinoma Collaboration Deals
* Late Stage Products (Phase III)
* TQB 2450: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* IPI-549: Infinity Pharmaceuticals
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* AVB-S6-500: Aravive Inc.
* Drug profiles in the detailed report.....
* Preclinical Stage Products
* Drug Name: Company name
* Drug profiles in the detailed report.....
* Inactive Products
* Renal Cell Carcinoma Key Companies
* Renal Cell Carcinoma Key Products
* Renal Cell Carcinoma - Unmet Needs
* Renal Cell Carcinoma - Market Drivers and Barriers
* Renal Cell Carcinoma - Future Perspectives and Conclusion
* Renal Cell Carcinoma Analyst Views
* Renal Cell Carcinoma Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=renal-cell-carcinoma-fda-approvals-clinical-trials-assessment-emerging-drugs-and-companies-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Renal Cell Carcinoma FDA Approvals, Clinical Trials Assessment, Emerging Drugs and Companies | DelveInsight here
News-ID: 3840181 • Views: …
More Releases from ABNewswire
Beyond Borders: How Global Expansion Is Redefining the Future of Business
Image: https://www.abnewswire.com/upload/2025/12/5e08c715e60fb92b1165ebe6377ef519.jpg
The world is witnessing a major shift in how companies operate, scale, and compete. As industries become increasingly interconnected and digital transformation accelerates, organizations are no longer confined to their local markets. Instead, they are leveraging global expansion strategies to tap into new revenue streams, access world-class talent, and build operational resilience.
From fast-growing startups to multinational enterprises, the ability to function as a global organization has become one of…
The Best Danish Technical Marketplaces in the Electronics Industry - A Thorough …
Denmark's electronics and technical industries are evolving at a rapid pace, and the demand for reliable technical information, in-depth product news and easy access to qualified suppliers has never been greater. In this landscape, two digital marketplaces stand out as the sector's daily tools for engineers, technicians, developers and decision-makers seeking insight, market overview and trustworthy business partners.
In this comparison, Altomteknik.dk and Electronic-supply.dk emerge as the two most influential technical…
Bryan Murphy Builder is Gifting Architectural Masterpieces to Austin Residents, …
Bryan Murphy Builder is providing residents in Austin with not just customized luxury homes but architectural masterpieces that they will always fall in love with and love to live in, every day, with immense pride and satisfaction.
Austin, TX - Dec 11, 2025 - Setting new benchmarks in luxury living, Bryan Murphy Builderis transforming visions into architectural masterpieces across Austin and the Hill Country. Having earned a name among the best…
Sacramento Homeowners Offered Free Same-Day Winter Garage Door Repair Consultati …
St. Mary's Garage Door Services, founded by Basem Tawadros and proudly serving Sacramento since 2013, is expanding its winter garage door repair and installation services across the Greater Sacramento Area, including Sacramento, Roseville, Folsom, Elk Grove, Citrus Heights, Rancho Cordova, Fair Oaks, Granite Bay, and surrounding communities. Homeowners can now schedule a free same-day repair consultation, ensuring fast, dependable service during the most demanding season for garage door systems.
Winter temperatures…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
